| [1] |
Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J]. CA Cancer J Clin, 2021, 71(3): 209-249.
|
| [2] |
Piché ME, Tchernof A, Després JP, et al. Obesity phenotypes, diabetes, and cardiovascular diseases [J]. Circ Res, 2020, 126(11): 1477-1500.
|
| [3] |
Brown KF, Rumgay H, Dunlop C, et al. The fraction of cancer attributable to modifiable risk factors in england, wales, scotland, northern Ireland, and the united kingdom in 2015 [J]. Br J Cancer, 2018, 118(8): 1130-1141.
|
| [4] |
Kyrgiou M, Kalliala I, Markozannes G, et al. Adiposity and cancer at major anatomical sites: umbrella review of the literature [J]. BMJ, 2017, 356: j477.
|
| [5] |
Giovannucci E, Harlan DM, Archer MC, et al. Diabetes and cancer: a consensus report [J]. Diabetes Care, 2010, 33(7): 1674-1685.
|
| [6] |
Park SW, Lee HL, Doo EY, et al. Visceral obesity predicts fewer lymph node metastases and better overall survival in colon cancer [J]. J Gastrointest Surg, 2015, 19(8): 1513-1521.
|
| [7] |
Abar L, Vieira AR, Aune D, et al. Height and body fatness and colorectal cancer risk: an update of the WCRF-AICR systematic review of published prospective studies [J]. Eur J Nutr, 2018, 57(5): 1701-1720.
|
| [8] |
Spychalski P, Kobiela J, Wieszczy P, et al. Clinical stages of colorectal cancer diagnosed in obese and overweight individuals in the Polish Colonoscopy Screening Program [J]. United European Gastroenterol J, 2019, 7(6): 790-797.
|
| [9] |
Li H, Yang G, Xiang YB, et al. Body weight, fat distribution and colorectal cancer risk: a report from cohort studies of 134255 Chinese men and women [J]. Int J Obes (Lond), 2013, 37(6): 783-789.
|
| [10] |
Mandic M, Safizadeh F, Niedermaier T, et al. Association of overweight, obesity, and recent weight loss with colorectal cancer risk [J]. JAMA Netw Open, 2023, 6(4): 239-556.
|
| [11] |
Low EE, Demb J, Liu L, et al. Risk factors for early-onset colorectal cancer [J]. Gastroenterology, 2020, 159(2): 492-501.
|
| [12] |
Lennon H, Sperrin M, Badrick E, et al. The obesity paradox in cancer: a Review [J]. Curr Oncol Rep, 2016, 18(9): 56.
|
| [13] |
Sedlak JC, Yilmaz ÖH, Roper J, et al. Metabolism and colorectal cancer [J]. Annu Rev Pathol, 2023, 18: 467-492.
|
| [14] |
Farinetti A, Zurlo V, Manenti A, et al. Mediterranean diet and colorectal cancer: A systematic review [J]. Nutrition, 2017, 43-44: 83-88.
|
| [15] |
Xu P, Li J, Liu J, et al. Mature adipocytes observed to undergo reproliferation and polyploidy [J]. FEBS Open Bio, 2017, 7(5): 652-658.
|
| [16] |
Ko JH, Um JY, Lee SG, et al. Conditioned media from adipocytes promote proliferation, migration, and invasion in melanoma and colorectal cancer cells [J]. J Cell Physiol, 2019,234(10): 18249-18261.
|
| [17] |
Wang Q, Su Y, Sun R, et al. MIIP downregulation drives colorectal cancer progression through inducing peri-cancerous adipose tissue browning [J]. Cell Biosci, 2024, 14(1): 12.
|
| [18] |
Ye P, Xi Y, Huang Z, et al. Linking obesity with colorectal cancer: epidemiology and mechanistic insights [J]. Cancers (Basel), 2020, 12(6): 1408.
|
| [19] |
Schumacher N, Rose-John S. ADAM17 activity and IL-6 trans-signaling in inflammation and cancer [J]. Cancers (Basel), 2019, 11(11): 1736.
|
| [20] |
Rodrigues KF, Pietrani NT, Bosco AA, et al. IL-6, TNF-α, and IL-10 levels/polymorphisms and their association with type 2 diabetes mellitus and obesity in Brazilian individuals [J]. Arch Endocrinol Metab, 2017, 61(5): 438-446.
|
| [21] |
Bou Malhab LJ, Abdel-Rahman WM. Obesity and inflammation: colorectal cancer engines [J]. Curr Mol Pharmacol, 2022, 15(4): 620-646.
|
| [22] |
Wang L, Chen L, Liu Z, et al. PAI-1 Exacerbates white adipose tissue dysfunction and metabolic dysregulation in high fat diet-Induced obesity [J]. Front Pharmacol, 2018, 9: 1087.
|
| [23] |
Chen H, Peng H, Liu W, et al. Silencing of plasminogen activator inhibitor-1 suppresses colorectal cancer progression and liver metastasis [J]. Surgery, 2015, 158(6): 1704-1713.
|
| [24] |
Lee CJ, Sears CL, Maruthur N. Gut microbiome and its role in obesity and insulin resistance [J]. Ann N Y Acad Sci, 2020, 1461(1): 37-52.
|
| [25] |
Cani PD, Jordan BF. Gut microbiota-mediated inflammation in obesity: a link with gastrointestinal cancer [J]. Nat Rev Gastroenterol Hepatol, 2018, 15(11): 671-682.
|
| [26] |
Mizutani S, Yamada T, Yachida S. Significance of the gut microbiome in multistep colorectal carcinogenesis [J]. Cancer Sci, 2020, 111(3): 766-773.
|
| [27] |
Jia W, Rajani C, Xu H, et al. Gut microbiota alterations are distinct for primary colorectal cancer and hepatocellular carcinoma [J]. Protein Cell, 2021, 12(5): 374-393.
|
| [28] |
Shuwen H, Miao D, Quan Q, et al. Protective effect of the "food-microorganism-SCFAs" axis on colorectal cancer: from basic research to practical application [J]. J Cancer Res Clin Oncol, 2019, 145(9): 2169-2197.
|
| [29] |
Chávez-Talavera O, Tailleux A, Lefebvre P, et al. Bile acid control of metabolism and inflammation in obesity, type 2 diabetes, dyslipidemia, and nonalcoholic fatty liver disease [J]. Gastroenterology, 2017, 152(7): 1679-1694.
|
| [30] |
Nguyen TT, Ung TT, Kim NH, et al. Role of bile acids in colon carcinogenesis [J]. World J Clin Cases, 2018, 6(13): 577-588.
|
| [31] |
Fu T, Coulter S, Yoshihara E, et al. FXR regulates intestinal cancer stem cell proliferation [J]. Cell, 2019, 176(5): 1098-1112.
|
| [32] |
Vigneri PG, Tirrò E, Pennisi MS, et al. The insulin/IGF system in colorectal cancer development and resistance to therapy [J]. Front Oncol, 2015, 5: 230.
|
| [33] |
Cheraghpour M, Askari M, Tierling S, et al. A systematic review and meta-analysis for the association of the insulin-like growth factor1 pathway genetic polymorphisms with colorectal cancer susceptibility [J]. Front Oncol, 2023, 13: 1168942.
|
| [34] |
Tognon CE, Sorensen PH. Targeting the insulin-like growth factor 1 receptor (IGF1R) signaling pathway for cancer therapy [J]. Expert Opin Ther Targets, 2012, 16(1): 33-48.
|
| [35] |
Xie Q, Chu Y, Yuan W, et al. Activation of insulin-like growth factor-1 receptor (IGF-1R) promotes growth of colorectal cancer through triggering the MEX3A-mediated degradation of RIG-I [J]. Acta Pharm Sin B, 2023, 13(7): 2963-2975.
|
| [36] |
Alrashid MH, Al-Serri AE, Hussain RF, et al. Association study of IGF-1 rs35767 and rs6214 gene polymorphisms with cancer susceptibility and circulating levels of IGF-1, IGFBP-2, and IGFBP-3 in colorectal cancer patients [J]. Biomedicines, 2023, 11(12): 3166.
|
| [37] |
Modzelewska P, Chludzińska S, Lewko J, et al. The influence of leptin on the process of carcinogenesis [J]. Contemp Oncol (Pozn), 2019, 23(2): 63-68.
|
| [38] |
Achari AE, Jain SK. Adiponectin, a therapeutic target for obesity, diabetes, and endothelial dysfunction [J]. Int J Mol Sci, 2017, 18(6): 1321.
|
| [39] |
Wang Y, Li J, Fu X, et al. Association of circulating leptin and adiponectin levels with colorectal cancer risk: A systematic review and meta-analysis of case-control studies [J]. Cancer Epidemiol, 2021, 73: 101958.
|
| [40] |
Saxena A, Baliga MS, Ponemone V, et al. Mucus and adiponectin deficiency: role in chronic inflammation-induced colon cancer [J]. Int J Colorectal Dis, 2013, 28(9): 1267-1279.
|
| [41] |
Otani K, Ishihara S, Yamaguchi H, et al. Adiponectin and colorectal cancer [J]. Surg Today, 2017, 47(2): 151-158.
|
| [42] |
Duraiyarasan S, Adefuye M, Manjunatha N, et al. Colon cancer and obesity: a narrative review [J]. Cureus, 2022, 14(8): e27589.
|
| [43] |
Yang G, Fan W, Luo B, et al. Circulating resistin levels and risk of colorectal cancer: a meta-analysis [J]. Biomed Res Int, 2016, 2016: 7367485.
|
| [44] |
Tarkowski A, Bjersing J, Shestakov A, et al. Resistin competes with lipopolysaccharide for binding to toll-like receptor 4 [J]. J Cell Mol Med, 2010, 14(6B): 1419-1431.
|
| [45] |
Hourdequin KC, Schpero WL, McKenna DR, et al. Toxic effect of chemotherapy dosing using actual body weight in obese versus normal-weight patients: a systematic review and meta-analysis [J]. Ann Oncol, 2013, 24(12): 2952-2962.
|
| [46] |
Makino T, Shukla PJ, Rubino F, et al. The impact of obesity on perioperative outcomes after laparoscopic colorectal resection [J]. Ann Surg, 2012, 255(2): 228-236.
|
| [47] |
Tsukamoto S, Nishizawa Y, Ochiai H, et al. Surgical outcomes of robot-assisted rectal cancer surgery using the da Vinci Surgical System: a multi-center pilot PhaseⅡstudy [J]. Jpn J Clin Oncol, 2017, 47(12): 1135-1140.
|
| [48] |
Marrone MT, Mondul AM, Prizment AE, et al. Lipid-lowering drug use and cancer incidence and mortality in the ARIC study [J]. JNCI Cancer Spectr, 2021, 5(5): pkab080.
|
| [49] |
Huang X, Sun T, Wang J, et al. Metformin reprograms tryptophan metabolism to stimulate CD8+ T-cell function in colorectal cancer [J]. Cancer Res, 2023, 83(14): 2358-2371.
|
| [50] |
Bendotti G, Montefusco L, Lunati ME, et al. The anti-inflammatory and immunological properties of GLP-1 receptor agonists [J]. Pharmacol Res, 2022, 182: 106320.
|
| [51] |
Alalwan AA, Friedman J, Park H, et al. US national trends in bariatric surgery: A decade of study [J]. Surgery, 2021, 170(1): 13-17.
|
| [52] |
Krishnan A, Hadi Y, Alqahtani SA, et al. Cardiovascular outcomes and mortality after bariatric surgery in patients with nonalcoholic fatty liver disease and obesity [J]. JAMA Netw Open, 2023, 6(4): e237188.
|
| [53] |
Renehan AG, Tyson M, Egger M, et al. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies [J]. Lancet, 2008, 371(9612): 569-578.
|
| [54] |
Ghiassi S, El Chaar M, Aleassa EM, et al. ASMBS position statement on the relationship between obesity and cancer, and the role of bariatric surgery: risk, timing of treatment, effects on disease biology, and qualification for surgery [J]. Surg Obes Relat Dis, 2020, 16(6): 713-724.
|
| [55] |
Afshar S, Malcomson F, Kelly SB, et al. Biomarkers of colorectal cancer risk decrease 6 months after roux-en-y gastric bypass surgery [J]. Obes Surg, 2018, 28(4): 945-954.
|
| [56] |
Chierici A, Amoretti P, Drai C, et al. Does bariatric surgery reduce the risk of colorectal cancer in individuals with morbid obesity? a systematic review and meta-analysis [J]. Nutrients, 2023, 15(2): 467.
|
| [57] |
Mackenzie H, Markar SR, Askari A, et al. Obesity surgery and risk of cancer [J]. Br J Surg, 2018, 105(12): 1650-1657.
|
| [58] |
Pararas N, Pikouli A, Dellaportas D, et al. The protective effect of bariatric surgery on the development of colorectal cancer: a systematic review and meta-analysis [J]. Int J Environ Res Public Health, 2023, 20(5): 3981.
|